Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsprofessional-practice-and-evidence

Paeds SAQs · professional-practice-and-evidence

Research ethics and assent in paediatric research — formative SAQs

Two formative short-answer questions on paediatric research ethics: risk-benefit categories and permission versus assent; and deferred consent with therapeutic misconception in emergency and oncology research.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
Prompt
Research ethics, permission and assent in paediatric research

SAQ 1 — Non-beneficial physiology study in children (10 marks)

A team proposes a non-beneficial study of disease physiology in school-age children. It requires two venepunctures the children would not otherwise undergo, and it cannot ethically be done in adults. The knowledge would be valuable to understanding the disorder. [1] [3]

Questions

  1. Under the Subpart D risk-benefit categories, into which tier does this study fall, and what must the ethics committee find to approve it? (4 marks) [1] [3]
  2. Distinguish parental permission, child assent and consent in this scenario, and state the age at which assent is typically sought. (3 marks) [2]
  3. How should the team handle a child's dissent, and when (if ever) could assent or permission be waived? (3 marks) [2] [3]

Model answer

Risk-benefit tier and approval (4). Because the study offers the child no prospect of direct benefit and carries more than minimal risk, it falls into the Subpart D category of a minor increase over minimal risk with no direct benefit. The ethics committee may approve it only if the intervention presents experiences reasonably commensurate with the child's situation, the risk is a minor increase over minimal risk, and the knowledge is of vital importance to understanding or ameliorating the participant's disorder and cannot be obtained otherwise. Parental permission alone cannot make a greater-than-minimal-risk non-beneficial study acceptable. [1] [3]

Permission, assent and consent (3). The parents give informed permission (authorisation) for the child to participate; the child, from about age 7 and adapted to development, gives assent (affirmative agreement). Consent is the legal authorisation a competent older adolescent may give for themselves, which a younger child cannot. The terms must not be conflated. [2]

Dissent and waiver (3). A child's dissent to non-beneficial research is generally binding and must be recorded. An ethics committee may waive assent or parental permission only if the research is minimal risk, it could not practicably be carried out with permission, and participants' rights and welfare are protected. This study is greater than minimal risk, so a waiver would not apply. [2] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Shah S, Whittle A, Wilfond B, Gensler G, Wendler D How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA, 2004.PMID 14747505
  2. [2]Wendler DS Assent in paediatric research: theoretical and practical considerations J Med Ethics, 2006.PMID 16574878
  3. [3]Kopelman LM Using the minimal risk threshold for all no-benefit pediatric studies Am J Bioeth, 2014.PMID 25127267
  4. [4]Unguru Y Ethical Challenges in Early-Phase Pediatric Research for Life-Limiting Illness Semin Pediatr Neurol, 2015.PMID 26358428
  5. [5]Moler FW, Silverstein FS, Holubkov R, et al Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials Pediatr Crit Care Med, 2013.PMID 23842585
  6. [6]Marron JM, Cronin AM, DuBois SG, et al. Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors JCO Precis Oncol, 2019.PMID 31240271
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousRefusal of treatment and disagreement over care — formative SAQsprofessional-practice-and-evidenceNextShared decision-making and assent in children — formative SAQsprofessional-practice-and-evidence